Sewell remains committed to lowering costs, protecting critical programs, and ensuring taxpayer dollars are used to improve the lives of American families.
Remain committed to lowering costs for American families.
Occurrences
I would like to thank my colleague Representative Miller for leading this effort, and I look forward to continue working with her to reduce costs for cancer survivors
Evidence
legacy_unverified · Source version not recorded · locator unknown
The official press-release index lists a June 9, 2026 entry titled "Rep. Sewell Votes Against Republican Reconciliation Bill."
legacy_unverified · Source version not recorded · locator unknown
The official site lists a June 16, 2026 press release titled "Rep. Sewell Secures $5 Million for Community Projects in Alabama's 7th Congressional District in FY27 Transportation-HUD Funding Bill."
legacy_unverified · Source version not recorded · locator unknown
Sewell's official "Lowering Rx Drug Costs" page says Medicare can negotiate certain drug prices under the Inflation Reduction Act and notes lower prices taking effect in January 2026 and additional negotiated prices effective in 2027.
Assessments
The claim is broad, but the strongest evidence shows Sewell supported and now highlights prescription-drug cost reductions under the Inflation Reduction Act, with some lower Medicare-negotiated prices taking effect in January 2026 while she remained in office. That supports meaningful same-term progress on one important household-cost category. However, the record here does not show that she broadly lowered costs for American families overall, and as one House member she merits shared rather than sole credit for the delivered outcome. The additional 2026 press releases show continued affordability-related engagement, but they do not by themselves prove broad cost reduction.